Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学CLL & Chronic Lymphocytic Leukemia

Constantine Tam

谭康斯坦丁

MBBS, MD, FRACP, FRCPA

🏢Royal Melbourne Hospital, University of Melbourne(皇家墨尔本医院/墨尔本大学)🌐Australia

Professor of Medicine; Director of Haematology, Royal Melbourne Hospital医学教授兼皇家墨尔本医院血液科主任

50
h-index
2
Key Papers
3
Awards
2
Key Contributions

👥Biography 个人简介

Prof. Constantine Tam is Australia's foremost CLL expert and a leading global advocate for time-limited venetoclax-based CLL therapy. His BOVen and other investigator-initiated trials have demonstrated that MRD-guided ibrutinib plus venetoclax can achieve deep remissions allowing treatment cessation in CLL.

Share:

🧪Research Fields 研究领域

CLL Venetoclax Time-Limited TherapyCLL维奈克拉有限疗程治疗
Ibrutinib Venetoclax CLL伊布替尼维奈克拉CLL
MRD-Guided CLLMRD指导CLL治疗

🎓Key Contributions 主要贡献

Time-Limited Venetoclax CLL Therapy

Led the BOVen trial (obinutuzumab plus ibrutinib plus venetoclax) demonstrating that triplet time-limited therapy achieves exceptionally high uMRD rates in frontline CLL, supporting treatment cessation and potentially curative intent approaches.

MRD-Guided Ibrutinib-Venetoclax Combinations

Pioneered MRD-guided ibrutinib plus venetoclax strategies in CLL, conducting landmark studies showing that sequential or simultaneous BTK-BCL2 combination achieves deep molecular responses enabling planned treatment discontinuation.

Representative Works 代表性著作

[1]

Ibrutinib plus Venetoclax for the Treatment of Mantle-Cell Lymphoma (AIM Trial)

New England Journal of Medicine (2018)

Demonstrated that BTK plus BCL2 inhibition achieves high MRD-negative complete response rates, establishing the foundation for time-limited combination therapy.

[2]

MRD-Guided Preemptive Venetoclax plus Obinutuzumab Therapy for CLL: Results of the BOVen Study

Journal of Clinical Oncology (2022)

BOVen trial demonstrating 85% uMRD negativity rates with triplet time-limited therapy in previously untreated CLL, enabling planned treatment cessation.

🏆Awards & Recognition 奖项与荣誉

🏆Haematology Society of Australia and New Zealand (HSANZ) Research Award
🏆NHMRC Career Development Fellowship
🏆Peter MacCallum Cancer Centre Excellence in Research Award

📄Data Sources 数据来源

Last updated: 2026-01-15 | All information from publicly available academic sources

关注 谭康斯坦丁 的研究动态

Follow Constantine Tam's research updates

留下邮箱,当我们发布与 Constantine Tam(Royal Melbourne Hospital, University of Melbourne)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment